URHC |
ERK/MAPK pathway |
Regulates cell proliferation and apoptosis |
[53] |
HULC |
RXRA pathway |
Modulates abnormal lipid metabolism |
[54] |
LINC00152 |
mTOR pathway |
Promotes proliferation in HCC |
[55] |
LINC01225 |
EGFR-dependent pathway |
Promotes occurrence and metastasis of HCC |
[56] |
CCHE1 |
ERK/MAPK pathway |
Promotes carcinogenesis of HCC |
[57] |
linc-cdh4-2 |
R-cadherin pathway |
Inhibits the migration and invasion of HCC cells |
[58] |
lncARSR |
PTEN-PI3K/Akt Pathway. |
Promotes doxorubicin resistance in HCC |
[59] |
TSLNC8 |
Interleukin-6/STAT3 pathway |
A tumor suppressor |
[60] |
PDIA3P1 |
p53 pathway |
Promotes cell proliferation, migration and invasion, and suppresses apoptosis |
[61] |
lncRNA00673 |
Notch pathway |
Promotes of proliferation and metastasis of HCC |
[62] |
Igf2as |
ERK/MAPK pathway |
Controls hepatocellular carcinoma progression |
[63] |
CCAL |
Wnt/β-catenin pathway |
Promotes HCC progression |
[64] |
LncDQ |
EMT Pathway |
Promotes HCC progression |
[65] |
lnc-Myd88 |
NF-κB and PI3K/AKT pathways |
Promotes HCC progression |
[66] |